ENHANCED ADENYLATE-CYCLASE ACTIVITY IN NEONATALLY DOPAMINE LESIONED RATS IS RELATED TO INCREASED GS-PROTEIN COUPLING

被引:24
作者
COWBURN, R
YOUNG, D
LUTHMAN, J
机构
[1] UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,C 236,DENVER,CO 80262
[2] KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT GERIATR MED,S-14186 HUDDINGE,SWEDEN
[3] UNIV COLORADO,HLTH SCI CTR,DEPT PREVENT MED & BIOMETR,DENVER,CO 80262
[4] UNIV COLORADO,HLTH SCI CTR,DEPT PSYCHIAT,DENVER,CO 80262
[5] KAROLINSKA INST,DEPT HISTOL & NEUROBIOL,S-10401 STOCKHOLM 60,SWEDEN
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1991年 / 207卷 / 03期
关键词
DOPAMINE D1-RECEPTORS; G-PROTEINS; CYCLIC ADENOSINE 3'; 5'-MONOPHOSPHATE; ADENYLATE CYCLASE; NEONATAL DOPAMINE LESION;
D O I
10.1016/0922-4106(91)90041-F
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has previously been shown that neonatal selective lesions of the central dopamine system with 6-hydroxydopamine lead to increased basal and dopamine-stimulated adenylate cyclase activity in striatum without any alterations of dopamine receptor binding characteristics. In the present study, it was shown that adenylate cyclase activity following G-protein stimulation by the GTP analogue 5-guanylimidodiphosphate (Gpp(NH)p) was increased in striatal preparations from neonatally 6-hydroxydopamine-lesioned rats, compared with control animals. No difference was seen in forskolin-stimulated enzyme activity between the two groups. These results indicate that neonatal dopamine lesions induce a selective functional supersensitivity at the D1 receptor complex by enhancing the coupling efficiency of the G(s) protein to adenylate cyclase, without altering the catalytic activity of the enzyme.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 10 条
  • [1] POSTNATAL-DEVELOPMENT OF STRIATAL DOPAMINE FUNCTION .2. EFFECTS OF NEONATAL 6-HYDROXYDOPAMINE TREATMENTS ON D1 AND D2 RECEPTORS, ADENYLATE-CYCLASE ACTIVITY AND PRESYNAPTIC DOPAMINE FUNCTION
    BROADDUS, WC
    BENNETT, JP
    [J]. DEVELOPMENTAL BRAIN RESEARCH, 1990, 52 (1-2): : 273 - 277
  • [2] DUNCAN GE, 1987, J PHARMACOL EXP THER, V243, P1027
  • [3] DOPAMINE-D1 RECEPTOR DEVELOPMENT DEPENDS ON ENDOGENOUS DOPAMINE
    GELBARD, HA
    TEICHER, MH
    BALDESSARINI, RJ
    GALLITANO, A
    MARSH, ER
    ZORC, J
    FAEDDA, G
    [J]. DEVELOPMENTAL BRAIN RESEARCH, 1990, 56 (01): : 137 - 140
  • [4] GIORGI O, 1988, P143
  • [5] HIRST K, 1990, THESIS U COLORADO HL
  • [6] LUTHMAN J, 1990, EXP BRAIN RES, V83, P85
  • [7] EFFECTS OF D-AMPHETAMINE AND METHYLPHENIDATE ON HYPERACTIVITY PRODUCED BY NEONATAL 6-HYDROXYDOPAMINE TREATMENT
    LUTHMAN, J
    FREDRIKSSON, A
    LEWANDER, T
    JONSSON, G
    ARCHER, T
    [J]. PSYCHOPHARMACOLOGY, 1989, 99 (04) : 550 - 557
  • [8] REPEATED RESERPINE ADMINISTRATION UP-REGULATES THE TRANSDUCTION MECHANISMS OF D1 RECEPTORS WITHOUT CHANGING THE DENSITY OF [H-3] SCH-23390 BINDING
    MISSALE, C
    NISOLI, E
    LIBERINI, P
    RIZZONELLI, P
    MEMO, M
    BUONAMICI, M
    ROSSI, A
    SPANO, P
    [J]. BRAIN RESEARCH, 1989, 483 (01) : 117 - 122
  • [9] ONALI P, 1985, MOL PHARMACOL, V28, P138
  • [10] SELECTIVE BRAIN DOPAMINE DEPLETION IN DEVELOPING RATS - EXPERIMENTAL-MODEL OF MINIMAL BRAIN-DYSFUNCTION
    SHAYWITZ, BA
    YAGER, RD
    KLOPPER, JH
    [J]. SCIENCE, 1976, 191 (4224) : 305 - 308